Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Cortex, Boston Scientific
Boston Scientific continues M&A run with Cortex buy
Cortex adds to Boston Scientific’s electrophysiology portfolio amid treatment shifts in the space driven by new pulsed field ablation devices.
Boston Scientific to bolster cardiac ablation portfolio with Cortex acquisition
Boston Scientific has signed a definitive agreement for the acquisition of an Ajax Health company, Cortex, to bolster its cardiac ablation portfolio. The companies did not disclose the financial terms of the deal.
Boston Scientific to acquire AFib ablation tech firm Cortex
Boston Scientific ( NYSE: BSX) has agreed to acquire privately held medical technology company, Cortex, Inc.
Boston Scientific to acquire Cortex, terms undisclosed
Boston Scientific (BSX) announced it has entered into a definitive agreement to acquire Cortex, Inc., an Ajax Health company. Cortex is a
Boston Scientific to Buy Medical-Technology Company Cortex
Boston Scientific has agreed to buy privately held medical- technology company Cortex from medical-device investor Ajax Health in a deal that bolsters its electrophysiology portfolio.
Boston Sci to acquire Cortex, expand AF portfolio
Boston Scientific Corp. signed a definitive agreement to acquire Cortex Inc., from Ajax Health Inc. to develop an integrated mapping and ablation solution for cardiac arrhythmias. Cortex’s Optimap system employs a basket catheter and algorithm to identify active sources for atrial fibrillation beyond the pulmonary veins on which most mapping and ablation technology currently focus.
Boston Scientific To Acquire Medical Technology Company Cortex; Terms Not Known
Monday said it has agreed to acquire medical technology company Cortex, Inc. Financial terms of the deal have not been disclosed. Cortex's OptiMap, a diagnostic mapping solution, helps physicians to identify triggers outside of the pulmonary veins that are foundational to atrial fibrillation (AF),
1d
Axonics' Market Growth Strengthens Boston Scientific's Future
Boston Scientific Corporation's acquisition of Axonics, Inc. for $3.7 billion expands urology offerings with innovative ...
1d
on MSN
Boston Scientific Corp. stock rises Tuesday, still underperforms market
Shares of Boston Scientific Corp. BSX inched 0.97% higher to $85.54 Tuesday, on what proved to be an all-around positive ...
WBJournal
1d
Boston Scientific to acquire California firm treating irregular heartbeats
Expanding its portfolio further into cardiovascular health, Marlborough medical device manufacturer Boston Scientific has ...
7d
Why is Boston Scientific Stock Trading Lower On Wednesday?
On Wednesday, Boston Scientific Corporation (NYSE:BSX) released the results of the primary endpoint of the ACURATE IDE trial ...
6d
Boston Scientific’s Acurate Neo2 inferior to rival TAVR valves in study
Analysts said the findings complicate the outlook for a U.S. launch of Boston Scientific's aortic valve replacement device.
MassDevice
7d
Boston Scientific Acurate neo2 TAVR misses primary endpoint in IDE trial
Boston Scientific (NYSE:BSX) today announced that a study of its Acurate neo2 aortic valve system missed its primary endpoint ...
3d
on MSN
Boston Scientific (BSX): A Promising Medical Stock with Strong Revenue Growth
We recently published a list of 8 Most Promising Medical Stocks According to Hedge Funds. In this article, we are going to ...
6d
Why The Fundamentals Make Me Bullish On Boston Scientific
Boston Scientific's strong history, margins, and pipeline make it a buy despite other analysts' Hold rating, with 15% growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback